Arban Domi

9 Patents

• US125775892026

  Vaccines and Uses Thereof to Induce an Immune Response to Sars-cov2

  Geovax, Inc.

  0 cites
• US123702492025

  Replication-deficient Modified Vaccinia Ankara (MVA) Expressing Marburg Virus Glycoprotein (GP) and Matrix Protein (VP40)

  Geovax, Inc.

  0 cites
• US123298082025

  Compositions and Methods for Generating an Immune Response to Treat or Prevent Malaria

  Geovax, Inc.

  0 cites
• US122472142025

  Vaccinia Viral Vectors Encoding Chimeric Virus Like Particles

  Geovax, Inc.

  0 cites
• US118966572024

  Replication-deficient Modified Vaccinia Ankara (MVA) Expressing Marburg Virus Glycoprotein (GP) and Matrix Protein (VP40)

  Geovax, Inc.

  0 cites
• US118576112024

  Compositions and Methods for Generating an Immune Response to Treat or Prevent Malaria

  Geovax, Inc.

  0 cites
• US118012992023

  Compositions and Methods for Generating an Immune Response to Hepatitis B Virus

  Georgia State University Research Foundation, Inc.

  0 cites
• US117014182023

  Replication-deficient Modified Vaccinia Ankara (MVA) Expressing Ebola Virus Glycoprotein (GP) and Matrix Protein (VP40)

  Geovax, Inc.

  0 cites
• US116387502023

  Methods for Generating a Zikv Immune Response Utilizing a Recombinant Modified Vaccina Ankara Vector Encoding the NS1 Protein

  Geovax, Inc.

  0 cites